# A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.

> **NCT05874622** · PHASE1 · COMPLETED · sponsor: **Jiangsu vcare pharmaceutical technology co., LTD** · enrollment: 30 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** VC005 tablets
- **DRUG:** VC005 Tablets Placebo

## Key facts

- **NCT ID:** NCT05874622
- **Lead sponsor:** Jiangsu vcare pharmaceutical technology co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-12
- **Primary completion:** 2023-10-18
- **Final completion:** 2023-10-25
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05874622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05874622, "A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05874622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*